These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14752219)

  • 1. DNA methylation markers in patients with gastrointestinal cancers. Current understanding, potential applications for disease management and development of diagnostic tools.
    Lofton-Day C; Lesche R
    Dig Dis; 2003; 21(4):299-308. PubMed ID: 14752219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent patents of DNA methylation biomarkers in gastrointestinal oncology.
    Corvalan AH; Maturana MJ
    Recent Pat DNA Gene Seq; 2010 Nov; 4(3):202-9. PubMed ID: 21073436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic diagnostics of cancer--the application of DNA methylation markers.
    Paluszczak J; Baer-Dubowska W
    J Appl Genet; 2006; 47(4):365-75. PubMed ID: 17132902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPARC and DNA methylation: possible diagnostic and therapeutic implications in gastrointestinal cancers.
    Nagaraju GP; El-Rayes BF
    Cancer Lett; 2013 Jan; 328(1):10-7. PubMed ID: 22939997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour.
    Okamoto Y; Sawaki A; Ito S; Nishida T; Takahashi T; Toyota M; Suzuki H; Shinomura Y; Takeuchi I; Shinjo K; An B; Ito H; Yamao K; Fujii M; Murakami H; Osada H; Kataoka H; Joh T; Sekido Y; Kondo Y
    Gut; 2012 Mar; 61(3):392-401. PubMed ID: 21708825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epigenetic Alterations in Gastrointestinal Cancers: Diagnostic and Therapeutic Applications].
    Ushijima T; Maeda M; Kawachi A
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):1-7. PubMed ID: 29362296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation and cancer pathways in gastrointestinal tumors.
    Suzuki H; Tokino T; Shinomura Y; Imai K; Toyota M
    Pharmacogenomics; 2008 Dec; 9(12):1917-28. PubMed ID: 19072648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation detection technology and plasma-based methylation biomarkers in screening of gastrointestinal carcinoma.
    Cao M; Zhang C; Zhou L
    Epigenomics; 2021 Aug; 13(16):1327-1339. PubMed ID: 34369810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation-based fecal biomarkers for the noninvasive screening of GI cancers.
    Goel A
    Future Oncol; 2010 Mar; 6(3):333-6. PubMed ID: 20222788
    [No Abstract]   [Full Text] [Related]  

  • 10. Practical Immunohistochemistry in Neoplastic Pathology of the Gastrointestinal Tract, Liver, Biliary Tract, and Pancreas.
    Wang HL; Kim CJ; Koo J; Zhou W; Choi EK; Arcega R; Chen ZE; Wang H; Zhang L; Lin F
    Arch Pathol Lab Med; 2017 Sep; 141(9):1155-1180. PubMed ID: 28854347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Diagnostics, Pathology and Biomarkers of Gastrointestinal Neoplasms.
    Gurzu S
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnostic applications of DNA methylation technology.
    Cottrell SE
    Clin Biochem; 2004 Jul; 37(7):595-604. PubMed ID: 15234241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives.
    Vedeld HM; Goel A; Lind GE
    Semin Cancer Biol; 2018 Aug; 51():36-49. PubMed ID: 29253542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer.
    Gerecke C; Scholtka B; Löwenstein Y; Fait I; Gottschalk U; Rogoll D; Melcher R; Kleuser B
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2097-107. PubMed ID: 25902909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles and causes of abnormal DNA methylation in gastrointestinal cancers.
    Suzuki H; Toyota M; Sato H; Sonoda T; Sakauchi F; Mori M
    Asian Pac J Cancer Prev; 2006; 7(2):177-85. PubMed ID: 16839207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic tumor markers in plasma and serum: biology and applications to molecular diagnosis and disease monitoring.
    Wong IH; Lo YM; Johnson PJ
    Ann N Y Acad Sci; 2001 Sep; 945():36-50. PubMed ID: 11708493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic field cancerization in gastrointestinal cancers.
    Baba Y; Ishimoto T; Kurashige J; Iwatsuki M; Sakamoto Y; Yoshida N; Watanabe M; Baba H
    Cancer Lett; 2016 Jun; 375(2):360-366. PubMed ID: 26971491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing gastrointestinal malignancies.
    Curtas S
    Semin Oncol Nurs; 1999 Feb; 15(1):10-6. PubMed ID: 10074653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of p16 and APC in gastrointestinal cancer patients.
    Erdem B; Küçükyıldırım S; Sağlar E; Polat Z; Mergen H
    Turk J Gastroenterol; 2014 Oct; 25(5):512-7. PubMed ID: 25417611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.